UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Leukemia, 2021-02, Vol.35 (2), p.312-332

2021

Volltextzugriff (PDF)

Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels

Molecular therapy. Oncolytics, 2022-12, Vol.27, p.203-203

Qian, Haili

2022

Volltextzugriff (PDF)

A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial–mesenchymal transition in tumor metastasis

Oncogene, 2020-03, Vol.39 (10), p.2125-2139

2020

Volltextzugriff (PDF)

A hidden translatome in tumors—the coding lncRNAs

Science China. Life sciences, 2023-12, Vol.66 (12), p.2755-2772

2023

Volltextzugriff (PDF)

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

Journal of biomedical science, 2024-01, Vol.31 (1), p.17-12, Article 17

2024

Volltextzugriff (PDF)

Chromatin modifier MTA1 regulates mitotic transition and tumorigenesis by orchestrating mitotic mRNA processing

Nature communications, 2020-09, Vol.11 (1), p.4455-17, Article 4455

2020

Volltextzugriff (PDF)

Enriched CD44+ /CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)

Cancer letters, 2014-10, Vol.353 (2), p.153-159

2014

Volltextzugriff (PDF)

MTA1: A Vital Modulator in Prostate Cancer

Current protein & peptide science, 2022-01, Vol.23 (7), p.456-464

2022

Volltextzugriff (PDF)

Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated

Cancer cell international, 2022-11, Vol.22 (1), p.1-341, Article 341

2022

Volltextzugriff (PDF)

The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials

BMC cancer, 2014-09, Vol.14 (1), p.683-683, Article 683

2014

Volltextzugriff (PDF)

Mesoscience in cell biology and cancer research

Cancer innovation (Print), 2022-12, Vol.1 (4), p.271-284

2022

Volltextzugriff (PDF)

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation

Nature communications, 2016-06, Vol.7 (1), p.ncomms11840-ncomms11840, Article ncomms11840

2016

Volltextzugriff (PDF)

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

BMC cancer, 2019-05, Vol.19 (1), p.442-442, Article 442

2019

Volltextzugriff (PDF)

Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer

Nucleic acids research, 2012-08, Vol.40 (14), p.6725-6740

2012

Volltextzugriff (PDF)

Aberrant O‐glycosylation contributes to tumorigenesis in human colorectal cancer

Journal of cellular and molecular medicine, 2018-10, Vol.22 (10), p.4875-4885

2018

Volltextzugriff (PDF)

ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR-mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon production

Cell communication and signaling, 2022-10, Vol.20 (1), p.156-16, Article 156

2022

Volltextzugriff (PDF)

Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency

Cell communication and signaling, 2023-03, Vol.21 (1), p.48-16, Article 48

2023

Volltextzugriff (PDF)

The molecular tumor burden index as a response evaluation criterion in breast cancer

Signal transduction and targeted therapy, 2021-07, Vol.6 (1), p.251-251, Article 251

2021

Volltextzugriff (PDF)

Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling

Signal transduction and targeted therapy, 2023-06, Vol.8 (1), p.247-247, Article 247

2023

Volltextzugriff (PDF)

The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significance

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920933036-1758835920933036

2020

Volltextzugriff (PDF)

The Clinical Characteristics of Endometrial Cancer With Extraperitoneal Metastasis and the Value of Surgery in Treatment

Technology in cancer research & treatment, 2020, Vol.19, p.1533033820945784-1533033820945784

2020

Volltextzugriff (PDF)

Upregulation of MTA1 in Colon Cancer Drives A CD8 + T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor Microenvironment

Frontiers in oncology, 2022-03, Vol.12, p.825783-825783

2022

Volltextzugriff (PDF)

PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer

Cell death & disease, 2023-04, Vol.14 (4), p.272-272, Article 272

2023

Volltextzugriff (PDF)

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers

Breast (Edinburgh), 2020-08, Vol.52, p.17-22

2020

Volltextzugriff (PDF)

The emerging role of RNA N6-methyladenosine methylation in breast cancer

Biomarker research, 2021-05, Vol.9 (1), p.1-39, Article 39

2021

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(207)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels

A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial–mesenchymal transition in tumor metastasis

A hidden translatome in tumors—the coding lncRNAs

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

Chromatin modifier MTA1 regulates mitotic transition and tumorigenesis by orchestrating mitotic mRNA processing

Enriched CD44+ /CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)

MTA1: A Vital Modulator in Prostate Cancer

Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated

The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials

Mesoscience in cell biology and cancer research

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer

Aberrant O‐glycosylation contributes to tumorigenesis in human colorectal cancer

ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR-mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon production

Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency

The molecular tumor burden index as a response evaluation criterion in breast cancer

Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling

The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significance

The Clinical Characteristics of Endometrial Cancer With Extraperitoneal Metastasis and the Value of Surgery in Treatment

Upregulation of MTA1 in Colon Cancer Drives A CD8 + T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor Microenvironment

PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers

The emerging role of RNA N6-methyladenosine methylation in breast cancer

Suchergebnisse filtern